Homeopathic medicines specialist King Bio enacts nationwide recall
August 24, 2018Medical Communications asheville, homeopathy, king bio, nc, recall
The Asheville-based drug maker King Bio is recalling 32 children’s medicines because of potential ‘microbial contamination’. The homeopathic medicines specialist …
Generics could save US Medicare $1 billion per year
August 24, 2018Medical Communications Medicare, United States, branded, generics, marketing, savings
The United States national health insurance programme Medicare could have save $1 billion through the use of generic drugs according …
Government publishes no-deal Brexit guidance, health secretary tells pharma companies to stockpile medicines
August 24, 2018Medical Communications ABPI, EU, UK, brexit, government, stockpiling
The British Government has published a document offering guidance as to what should be expected in the case of a …
GE Healthcare set to open biotech hub in Uppsala, Sweden
August 23, 2018Manufacturing and Production, Research and Development GE Healthcare, Sweden, Testa Centre, Uppsala, biotech
The American multinational GE Healthcare is opening a 27,000-sq-ft innovation centre in Uppsala, Sweden in an effort to boost the …
AstraZeneca shocked as inhaler fails to outclass GSK rival in COPD
August 23, 2018Research and Development AstraZeneca, COPD, GSK, anoro, inhaler, pharma
Researchers at AstraZeneca have been left scratching their heads as new Phase 3b results for its inhaler, Bevespi Aerosphere, posted …
$3 million GSK verdict thrown out of court
August 23, 2018Sales and Marketing GSK, Litigation, antidepressants, suicide, verdict
A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said that GSK …
Novartis’ investigational combo impresses in breast cancer sub-group
August 23, 2018Research and Development Cancer, Novartis, breast cancer, fulvestrant, pharma
Novartis has revealed positive new data for its investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) combined with fulvestrant in the treatment …
Nerve stimulation treatments improve quality of life in depressed people, study shows
August 23, 2018Research and Development VNS, depression, neuroscience, psychiatry, quality of life, vagus nerve stimulators
Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …
FDA refuses Allergan’s uterine bleeding therapy with a request for more data
August 22, 2018Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma
Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …
Brexit Health Alliance calls for effective planning for no-deal Brexit
August 22, 2018Research and Development Brexit Health Alliance, Labour, NHS, brexit, no-deal
Niall Dickson, co-chair of the Brexit Health Alliance has called for immediate comprehensive and effective plans for a no deal …
Novo Nordisk buys Bristol University biotech in £620m deal
August 22, 2018Research and Development Bristol, Novo Nordisk, Ziylo, diabetes
Novo Nordisk has bought a tiny biotech company spun out of Bristol University in a deal that could be worth …
Blockchain deployed in fight against fake pharmaceuticals in India
August 22, 2018Research and Development India, NITI, blockchain, pharma, technology
Indian policymakers in collaboration with an Indian hospital chain and an American multinational, have initiated plans to deploy blockchain technology …
Alex Azar says his agency has the power to eliminate pharmaceutical rebates
August 21, 2018Research and Development Alex Azar, Rebates, Trump, US government, pbm
US Health and Human Services Secretary Alex Azar has said in an interview with Reuters, that it is within the …
Novo’s semaglutide hits the mark in Phase 3 type 2 diabetes study
August 21, 2018Manufacturing and Production, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes
Novo Nordisk has revealed new Phase 3a data on its glucagon-like peptide-1 (GLP-1) analogue oral semaglutide in the treatment of …
Leaked letter warns of NHS disruption after Brexit
August 21, 2018Manufacturing and Production NHS, The Times, brexit, hard Brexit
NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is …
Japan approves AstraZeneca’s Tagrisso in EGFRm non-small cell lung cancer
August 21, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Japan, Tagrisso, lung cancer, pharma
AstraZeneca has revealed that its EGFR tyrosine kinase inhibitor Tagrisso (osimertinib) has been approved in Japan by the nation’s Ministry …
Further six officials fired from China FDA
August 21, 2018Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal
A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …
Prozac prevents cognitive decline during normal aging process, study shows
August 21, 2018Manufacturing and Production MIT, Picower Institute, Prozac, antidepressants, mice, neuroscience
A study conducted by MIT’s Picower Institute for Learning and Memory has reinforced the notion that loss in the capacity …
FDA approves Bristol Myers Squibb’s Opdivo in small-cell lung cancer
August 20, 2018Sales and Marketing Bristol-Myers Squibb, FDA, approval, bristol myers squibb, lung cancer, opdivo
The FDA has approved Bristol Myers Squibb’s Opdivo (nivolumab) for patients with metastatic small-cell lung cancer (SCLC), as the first …
Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration
August 20, 2018Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma
Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
